Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
alzheimer's disease
2
×
biotech
boston blog main
boston top stories
deals
gene editing
2
×
life sciences
national blog main
san francisco blog main
allergan
allergan aesthetics
amgen
astrazeneca
athira pharma
attralus
biontech
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
clinical trials
covid-19
crispr
cullinan oncology
cynthia collins
cystic fibrosis
daniel o'day
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
dogma therapeutics
dyne therapeutics
editas medicine
What
abbvie
acquisitions
alliance
biggest
bio
biotech
build
buy
ceo
company’s
daniel
debut
drug
dyne’s
editas
editing
exits
experimental
gene
genetic
gilead
medicines
microbiome
moves
openly
o’day
pact
partnership
pipeline
pruning
research
returning
rights
roundup
sciences
scores
seagen
spoken
terminated
treatment
Language
unset
2
×
Current search:
abbvie
×
unset
×
" alzheimer's disease "
×
" gene editing "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
